IXICO (IXI) Competitors GBX 9.50 +0.50 (+5.56%) As of 03:56 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock IXI vs. COS, C4XD, DDDD, FUM, OKYO, AOR, SAR, OPTI, AREC, and POLBShould you be buying IXICO stock or one of its competitors? The main competitors of IXICO include Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), Futura Medical (FUM), OKYO Pharma (OKYO), AorTech International (AOR), Sareum (SAR), OptiBiotix Health (OPTI), Arecor Therapeutics (AREC), and Poolbeg Pharma (POLB). These companies are all part of the "biotechnology" industry. IXICO vs. Collagen Solutions plc (COS.L) C4X Discovery 4D pharma Futura Medical OKYO Pharma AorTech International Sareum OptiBiotix Health Arecor Therapeutics Poolbeg Pharma Collagen Solutions plc (COS.L) (LON:COS) and IXICO (LON:IXI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, community ranking, risk, earnings, valuation and institutional ownership. Which has better earnings and valuation, COS or IXI? Collagen Solutions plc (COS.L) has higher earnings, but lower revenue than IXICO. IXICO is trading at a lower price-to-earnings ratio than Collagen Solutions plc (COS.L), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCollagen Solutions plc (COS.L)£4.01M0.00N/A-£0.80N/AIXICO£11.50M0.77-£3.58M-£3.86-2.46 Does the MarketBeat Community favor COS or IXI? IXICO received 15 more outperform votes than Collagen Solutions plc (COS.L) when rated by MarketBeat users. However, 72.88% of users gave Collagen Solutions plc (COS.L) an outperform vote while only 71.64% of users gave IXICO an outperform vote. CompanyUnderperformOutperformCollagen Solutions plc (COS.L)Outperform Votes12972.88% Underperform Votes4827.12% IXICOOutperform Votes14471.64% Underperform Votes5728.36% Does the media refer more to COS or IXI? In the previous week, Collagen Solutions plc (COS.L)'s average media sentiment score of 0.00 equaled IXICO'saverage media sentiment score. Company Overall Sentiment Collagen Solutions plc (COS.L) Neutral IXICO Neutral Do institutionals and insiders hold more shares of COS or IXI? 56.0% of IXICO shares are owned by institutional investors. 30.3% of IXICO shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is COS or IXI more profitable? Collagen Solutions plc (COS.L) has a net margin of 0.00% compared to IXICO's net margin of -31.10%. Collagen Solutions plc (COS.L)'s return on equity of 0.00% beat IXICO's return on equity.Company Net Margins Return on Equity Return on Assets Collagen Solutions plc (COS.L)N/A N/A N/A IXICO -31.10%-19.14%-10.40% SummaryCollagen Solutions plc (COS.L) and IXICO tied by winning 5 of the 10 factors compared between the two stocks. Get IXICO News Delivered to You Automatically Sign up to receive the latest news and ratings for IXI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IXI vs. The Competition Export to ExcelMetricIXICOBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£8.80M£124.05M£5.51B£2.56BDividend Yield1.27%3.69%5.11%4.97%P/E Ratio-2.463.2422.55132.23Price / Sales0.774,173.49394.97226,804.17Price / Cash2.2513.0238.1828.13Price / Book0.4933.276.694.52Net Income-£3.58M-£90.45M£3.22B£5.84B7 Day Performance3.32%3.68%1.11%2.95%1 Month Performance20.56%5.10%3.59%9.02%1 Year Performance17.72%95.21%15.65%114.57% IXICO Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IXIIXICON/AGBX 9.50+5.6%N/AN/A£8.80M£11.50M-2.4689Gap UpCOSCollagen Solutions plc (COS.L)N/AN/AN/AN/A£30.99M£4.01M-8.283,350C4XDC4X DiscoveryN/AN/AN/AN/A£30.27M£24.68M300.0049High Trading VolumeDDDD4D pharmaN/AN/AN/AN/A£30.05M£718,000.00-1.08106News CoverageFUMFutura MedicalN/AGBX 9.62+3.4%N/A-72.4%£29.98M£8.68M-7.9412Gap UpOKYOOKYO PharmaN/AN/AN/AN/A£23.24MN/A-140.007Gap DownAORAorTech InternationalN/AN/AN/AN/A£19.99M£539,000.00-33.383SARSareumN/AGBX 16-7.2%N/A-28.8%£19.99MN/A-3.793,211Gap DownOPTIOptiBiotix HealthN/AGBX 19.33+0.4%N/A+1.2%£18.93M£590,009.23-6.121ARECArecor TherapeuticsN/AGBX 38.17+0.5%N/A-71.0%£14.41M£6.04M-1.3510Positive NewsHigh Trading VolumePOLBPoolbeg PharmaN/AGBX 2.74+1.5%N/A-73.2%£14.08MN/A0.0012Gap Down Related Companies and Tools Related Companies COS Competitors C4XD Competitors DDDD Competitors FUM Competitors OKYO Competitors AOR Competitors SAR Competitors OPTI Competitors AREC Competitors POLB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:IXI) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IXICO plc Please log in to your account or sign up in order to add this asset to your watchlist. Share IXICO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IXI Stock Free IXI Stock Alerts